Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

ClinicalTrials.gov ID: NCT01466374

Public ClinicalTrials.gov record NCT01466374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease

Study identification

NCT ID
NCT01466374
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • BMS-936557 (Anti-IP-10 Antibody) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
May 31, 2014
Completion
Nov 30, 2014
Last update posted
Oct 11, 2015

2011 – 2014

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Southern California Medical Gastroenterology Group Santa Monica California 90404
Shafran Gasteroenterology Center Winter Park Florida 32789
Gastroenterology Research Of New Orleans Hammond Louisiana 70403
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr Chevy Chase Maryland 20815
Midwest Center For Clinical Research Lees Summit Missouri 64064
Nyu Langone Long Island Clinical Research Associates Great Neck New York 11021
Mount Sinai School Of Medicine New York New York 10029
University Of North Carolina At Chapel Hill Chapel Hill North Carolina 27599
Consultants For Clinical Research Cincinnati Ohio 45219
Gastroenterology Research Of San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01466374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2015 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01466374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →